Evidence map›Paper›PMID 25288000›Full record

ArticleChest2014

Preventing ARDS: progress, promise, and pitfalls.

Jeremy R Beitler, David A Schoenfeld, B Taylor Thompson

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Chest, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02759770 (Risk Factors and Prediction Score of ARDS After Cardiac Surgery), which is not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02759770 completednot on this mapstarted 2017, after this paper: background citation

Risk Factors and Prediction Score of ARDS After Cardiac Surgery

TypeobservationalSponsorBeijing Anzhen HospitalRan2017 to 2017Enrolled1,333ConditionsRespiratory Distress Syndrome, Adult, Thoracic Surgery, Risk FactorsArmsno intervention
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Protection procedures and preventions against the spread of coronavirus disease 2019 in healthcare settings for nursing personnel: Lessons from Taiwan.Australian critical care : official journal of the Confederation of Australian Critical Care Nurses · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Optimal Ventilator Strategies in Acute Respiratory Distress Syndrome.Seminars in respiratory and critical care medicine · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jeremy R BeitlerDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital.
David A SchoenfeldBiostatistics Center, Department of Medicine, Massachusetts General Hospital, Boston, MA.
B Taylor ThompsonDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital; Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: tthompson1@partners.org.
Brigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
Mesenchymal Stromal Cell Conditioning by Carbon MonoxideP01HL108801 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOI, AUGUSTINE M · 2011 to 2015
$13.8M
MOLECULAR EPIDEMIOLOGY OF ARDSR01HL060710 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2000 to 2015
$8.4M
NHLBI NIH HHS 1-P01-HL108801NHLBI NIH HHS 5-R01-HL60710-9NHLBI NIH HHS 5-T32-HL007633NHLBI NIH HHS P01 HL108801NHLBI NIH HHS R01 HL060710NHLBI NIH HHS T32 HL007633
6 · The paper itself

Abstract

Advances in critical care practice have led to a substantial decline in the incidence of ARDS over the past several years. Low tidal volume ventilation, timely resuscitation and antimicrobial administration, restrictive transfusion practices, and primary prevention of aspiration and nosocomial pneumonia have likely contributed to this reduction. Despite decades of research, there is no proven pharmacologic treatment of ARDS, and mortality from ARDS remains high. Consequently, recent initiatives have broadened the scope of lung injury research to include targeted prevention of ARDS. Prediction scores have been developed to identify patients at risk for ARDS, and clinical trials testing aspirin and inhaled budesonide/formoterol for ARDS prevention are ongoing. Future trials aimed at preventing ARDS face several key challenges. ARDS has not been validated as an end point for pivotal clinical trials, and caution is needed when testing toxic therapies that may prevent ARDS yet potentially increase mortality.

Indexed as

Critical CareHumansIncidenceLung InjuryRespiratory Distress Syndrome

Identifiers

PMID25288000
PMCPMC4188145
OpenAlexW2063785944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.